Moody's Investors Service affirmed its "A2" rating on Columbia, Md.-based MedStar Health, affecting $1.4 billion of debt.
The affirmation reflects MedStar's diversified clinical delivery network, which Moody's believes will translate to further enterprise growth and strengthen the system's market position.
The rating outlook remains stable.